Organon (MIL:1OGN) Beta: N/A (As of Jul. 04, 2026)


MIL:1OGN Organon & Co MIL:1OGN
44 GF Score
Price €11.93
GF Value €12.80
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Organon Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-04), Organon's Beta is Not available.

Organon  (MIL:1OGN) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Organon Beta Related Terms

Organon Beta Historical Data

* Premium members only.

The historical data trend for Organon's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organon Beta Chart

Organon Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Organon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MIL:1OGN
44GF Score
Organon & Co MIL:1OGN
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organon Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Organon (MIL:1OGN) Overvalued in 2026?

Based on GuruFocus' analysis, Organon stock appears to be undervalued. The current stock price of €11.93 is trading 6.8% below its estimated GF Value™ of €12.80. GuruFocus considers Organon to be Fairly Valued.

Key valuation signals for MIL:1OGN:

  • Beta: N/A
  • GF Value™: €12.80 vs. price of €11.93 (6.8% below fair value)
  • GF Score™: 44/100 with 10 warning signs

No single metric tells the full story. See the MIL:1OGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Organon Business Description

Address 30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
44GF Score

Get the complete analysis for MIL:1OGN

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.93
Price
€12.80
GF Value